EUVIMEDObjevte EUVIMED
Randomisierte kontrollierte Studie

In people with diabetic kidney disease, is there randomized controlled trial evidence to support the use of angiotensin converting enzyme inhibitors and angiotensin II receptor antagonists to prevent progression?

William Cayley Jr

Cochrane Clinical Answers · 2013

DOI: 10.1002/cca.100 ↗

At a glance

Randomisierte kontrollierte Studie in Cochrane Clinical Answers, 2013. Written by William Cayley Jr. 27 references.

AbstraktBibliografické údajeCiteRelated studies

Abstract (original language)

Není k dispozici žádný abstrakt.

Cite

APA

Jr, W. C. (2013). In people with diabetic kidney disease, is there randomized controlled trial evidence to support the use of angiotensin converting enzyme inhibitors and angiotensin II receptor antagonists to prevent progression?. Cochrane Clinical Answers. https://doi.org/10.1002/cca.100

Vancouver

Jr WC. In people with diabetic kidney disease, is there randomized controlled trial evidence to support the use of angiotensin converting enzyme inhibitors and angiotensin II receptor antagonists to prevent progression?. Cochrane Clinical Answers. 2013. doi:10.1002/cca.100

BibTeX
@article{Jr2013,
  author = {Jr, William Cayley},
  title = {In people with diabetic kidney disease, is there randomized controlled trial evidence to support the use of angiotensin converting enzyme inhibitors and angiotensin II receptor antagonists to prevent progression?},
  journal = {Cochrane Clinical Answers},
  year = {2013},
  doi = {10.1002/cca.100}
}
Start for free →